Lenacapavir (SUNLENCA)
Ended Awarded
- Contract number
- 36C26125N0499
- Awardee
-
Gilead Sciences Inc. UEI FPJMGUK1BYH8
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $14,894
Award facts
- Contract value 100% obligated
- $14,894.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Palo Alto, CA 94304, USA
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order contract awarded by the Veterans Integrated Service Network 21 (VISN 21), which is part of the U.S. Department of Veterans Affairs (VA), to Gilead Sciences Inc. The contract is for the pharmaceutical product Lenacapavir (Sunlenca), which is used to treat HIV. The contract has a firm fixed price of $14,894.47 and a period of performance ending on July 14, 2025. The contract was awarded on May 14, 2025 and is not set aside for small businesses. Gilead Sciences Inc. is a prominent biopharmaceutical company that has established itself as a critical supplier of specialized pharmaceutical products to the VA and other federal healthcare programs, particularly for complex and life-threatening conditions affecting veterans and other federal healthcare beneficiaries.
Quick answers
Who was awarded contract 36C26125N0499?
36C26125N0499 was awarded to Gilead Sciences Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on May 14, 2025.
How much is contract 36C26125N0499 worth?
The government has obligated $14,894 on 36C26125N0499.
Is contract 36C26125N0499 an order under another contract?
Yes. 36C26125N0499 is a delivery order under V797D70252, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26125N0499 competed?
The extent of competition for 36C26125N0499 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award